Abstract
Cyclosporine (CsA) efficacy in nephrotic syndrome (NS) from primary glomerulonephritis (GN) other than minimal changes GN is still controversial (1); moreover CsA has been generally employed at high doses and / or associated to steroids (2, 3). Its interference with lymphokines more than haemodynamic effect has been emphasized (4, 5). In order to test CsA efficacy in NS and in the attempt to avoid dose-related or steroid associated side effects, we started an open self-controlled therapeutic trial with low-dose CsA alone.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
De Santo N.G., Capodicasa G., Giordano C., Am. J. Nephrol., 7, 74–76 (1987)
Balcke, P., Derfler. K. Stockenhuber. F. et al., Wien. Klin. Wschr. 99, 242–245 (1987)
Chan, M.K. and Cheng, I.K.P., Postgrad. med. J. 63, 757–759 (1987)
Capodicasa, G., De Santo, N.G., Nuzzi, F. et al, Int. J. Pediat. Nephrol. 7, No.2, 69–72 (1986)
Tejani, A., Butt, K., Trachtman, H. et al., Kidney Int. 33, 729–734 (1988)
Hess, A. D., Prog Allergy 38. 198–221 (1986)
Koenig, P., Defregger M, Dittrich P., 2nd Int. Congress on Cyclosporine (Abst.), Washigton, 79.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Confalonieri, R. et al. (1989). Cyclosporine Effect on Corticoresistant Nephrotic Syndrome in Primary Glomerulonephritis. In: Andreucci, V.E., Dal Canton, A. (eds) Current Therapy in Nephrology. Developments in Nephrology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0865-2_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0865-2_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8209-9
Online ISBN: 978-1-4613-0865-2
eBook Packages: Springer Book Archive